NCT00163475View on ClinicalTrials.gov

Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)

PHASE3CompletedINTERVENTIONAL

Enrollment

511

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions

Asthma

Interventions

DRUG

Roflumilast

Trial Locations (5)

Unknown

ALTANA Pharma, Cities in Australia

ALTANA Pharma, Cities in Belgium

ALTANA Pharma, Cities in France

ALTANA Pharma, Cities in South Africa

ALTANA Pharma, Cities in Spain

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY